Henry Schein, Inc. (HSIC) Stock Rating Reaffirmed by Jefferies Group LLC
Henry Schein, Inc. (NASDAQ:HSIC)‘s stock had its “hold” rating reaffirmed by Jefferies Group LLC in a report released on Friday. They presently have a $89.00 target price on the stock. Jefferies Group LLC’s price target points to a potential upside of 5.29% from the company’s current price. Jefferies Group also issued estimates for Henry Schein’s Q4 2017 earnings at $0.98 EPS, FY2017 earnings at $3.63 EPS, Q3 2018 earnings at $0.98 EPS, Q4 2018 earnings at $1.03 EPS and FY2018 earnings at $3.95 EPS.
Several other equities analysts have also commented on the company. Robert W. Baird set a $95.00 price target on Henry Schein and gave the company a “buy” rating in a research note on Thursday. Stifel Nicolaus reaffirmed a “hold” rating and issued a $89.00 price target on shares of Henry Schein in a research note on Thursday. Morgan Stanley assumed coverage on Henry Schein in a research note on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price target on the stock. Royal Bank Of Canada assumed coverage on Henry Schein in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $91.00 price target on the stock. Finally, UBS AG reaffirmed a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and six have issued a buy rating to the company’s stock. Henry Schein has a consensus rating of “Hold” and a consensus target price of $92.89.
Henry Schein (NASDAQ:HSIC) traded up 1.73% during mid-day trading on Friday, hitting $84.53. The stock had a trading volume of 1,054,733 shares. The company has a market cap of $13.37 billion, a PE ratio of 24.70 and a beta of 1.08. The firm’s 50-day moving average price is $82.46 and its 200 day moving average price is $87.26. Henry Schein has a one year low of $73.11 and a one year high of $93.50.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the prior year, the company posted $0.82 EPS. The company’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities research analysts anticipate that Henry Schein will post $3.64 EPS for the current year.
Henry Schein declared that its board has initiated a stock buyback program on Monday, September 18th that permits the company to buyback $400.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.
In related news, SVP Paul Rose sold 2,126 shares of the stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.19% of the stock is currently owned by corporate insiders.
Hedge funds have recently bought and sold shares of the business. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC raised its position in Henry Schein by 8,185.7% in the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares in the last quarter. Lee Financial Co acquired a new stake in Henry Schein in the 2nd quarter valued at about $161,000. Acrospire Investment Management LLC raised its position in Henry Schein by 150.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after purchasing an additional 600 shares in the last quarter. Finally, HM Payson & Co. acquired a new stake in Henry Schein in the 2nd quarter valued at about $204,000. 44.74% of the stock is currently owned by institutional investors.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.